| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |